Loading viewer...
investor_presentation
Format: PDF investor_presentation
Apogee Enterprises presented its strategic growth initiatives and financial outlook in June 2016, highlighting sustainable revenue growth across new geographies and products, operational margin improvements, and a strong balance sheet. The company provided FY17 guidance targeting 10% revenue growth and operating margins of at least 11%, with FY18 targets of $1.2-1.3 billion in revenues exceeding 12% operating margins.
presentation
Regeneron Pharmaceuticals Investor Presentation — June 2019
investor_presentationinvestor_presentation
25 Pages
Regeneron Pharmaceuticals, Inc.